Cellworks Study Predicted Non-Response to Azacitidine in MDS Patients with 100% Accuracy using AI-Driven Biosimulation
Analysis Uncovered Possible Mechanisms for AZA Resistance that could be Targeted to Induce…
Cellworks AI-Driven Biosimulation Predicted Chemo-resistance in AML and MDS Patients with 90% Accuracy
Prospective Study Successfully Identified Mechanisms for AML…
Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting
ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual…
Former UnitedHealth Group Cancer Director Dr. Lee Newcomer Joins Cellworks Board of Directors
Leading Precision Medicine Company Adds to Prestigious Board of Directors, which includes Dr.…
